Clinical practice guidelines for the management of biliary tract cancers 2015: The 2nd English edition

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 22, Issue 4, 2015, Pages 249-273

  Miyazaki, Masaru ^a   Yoshitomi, Hideyuki ^a   Miyakawa, Shuichi ^b   Uesaka, Katsuhiko ^c   Unno, Michiaki ^d   Endo, Itaru ^e   Ota, Takehiro ^f   Ohtsuka, Masayuki ^a   Kinoshita, Hisafumi ^g   Shimada, Kazuaki ^h   Shimizu, Hiroaki ^a   Tabata, Masami ⁱ   Chijiiwa, Kazuo ^j   Nagino, Masato ^k   Hirano, Satoshi ^l   Wakai, Toshifumi ^m   Wada, Keita ⁿ   Iasayama, Hiroyuki ^o   Okusaka, Takuji ^h   Tsuyuguchi, Toshio ^a   Fujita, Naotaka ^p   Furuse, Junji ^q   Yamao, Kenji ^r   Murakami, Koji ^s   Yamazaki, Hideya ^t   Kijima, Hiroshi ^u   Nakanuma, Yasuni ^c   Yoshida, Masahiro ^v   Takayashiki, Tsukasa ^a   Takada, Tadahiro ⁿ   more..

^a CHIBA UNIVERSITY   (Japan)

^b Toyota Regional Medical Center   (Japan)

^c SHIZUOKA CANCER CENTER   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f Department of Dentistry Oral surgery   (Japan)

^g KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NATIONAL CANCER CENTER HOSPITAL   (Japan)

ⁱ Matsusaka Central Hospital   (Japan)

^j UNIVERSITY OF MIYAZAKI   (Japan)

^k NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

ⁿ TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o UNIVERSITY OF TOKYO   (Japan)

^p Miyagi Medical Check up Plaza ^*  (Japan)

^q KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r AICHI CANCER CENTER HOSPITAL   (Japan)

^s KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^t KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^u HIROSAKI UNIVERSITY   (Japan)

^v INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

more..

Author keywords

Ampullary carcinoma; Bile duct carcinoma; Biliary tract cancer; Gallbladder carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

BILE DUCT CANCER; BILE DUCT CARCINOMA; BILIARY STENT; BILIARY TRACT CANCER; BILIARY TRACT DRAINAGE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGISTRY; CHOLECYSTECTOMY; EVIDENCE BASED MEDICINE; HUMAN; PRACTICE GUIDELINE; REVIEW; BILIARY TRACT NEOPLASMS; DISEASE MANAGEMENT; STANDARDS;

BILIARY TRACT NEOPLASMS; DISEASE MANAGEMENT; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84925963050     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.233     Document Type: Review

References (253)

1. Takada T,. Clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 1.
2. Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 2-6.
3. Miyakawa S, Ishihara S, Takada T, Miyazaki M, Tsukada K, Nagino M, et al. Flowcharts for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 7-14.
4. Miyazaki M, Takada T, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors. J Hepatobiliary Pancreat Surg. 2008; 15: 15-24.
5. Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 25-30.
6. Tsukada K, Takada T, Miyazaki M, Miyakawa S, Nagino M, Kondo S, et al. Diagnosis of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 31-40.
7. Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008; 15: 41-54.
8. Furuse J, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Guidelines for chemotherapy of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 55-62.
9. Tsuyuguchi T, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 69-73.
10. Saito H, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008; 15: 63-68.
11. Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012; 61: 1657-69.
12. Benson AB, D'Angelica MI, Abrams TA, Are C, Bloomston M, Brown D, et al. NCCN clinical practice guidelines in Oncology. Hepatobiliary cancers. 2015. Available from: http://www.nccn.org/professionals/physician-gls/pdf/hepatobiliary.pdf.
13. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004; 328: 1490.
14. Yoshitomi H, Miyakawa S, Nagino M, Takada T, Miyazaki M,. Updated clinical practice guidelines for the management of biliary tract cancers: revision concepts and major revised points. J Hepatobiliary Pancreat Sci. 2015; 22: 274-8.
15. Working group IAP/APA acute pancreatitis guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013; 13: e1-15.
16. Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gomi H, Yoshida M, et al. TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013; 20: 1-7.
17. Kamisawa T, Ando H, Suyama M, Shimada M, Morine Y, Shimada H,. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol. 2012; 47: 731-59.
18. Shimada K, Yanagisawa J, Nakayama F,. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology. 1991; 13: 438-44.
19. Funabiki T, Matsubara T, Miyakawa S, Ishihara S,. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch Surg. 2009; 394: 159-69.
20. Morine Y, Shimada M, Takamatsu H, Araida T, Endo I, Kubota M, et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013; 20: 472-80.
21. Takeshita N, Ota T, Yamamoto M,. Forty-year experience with flow-diversion surgery for patients with congenital choledochal cysts with pancreaticobiliary maljunction at a single institution. Ann Surg. 2011; 254: 1050-53.
22. Tsuchida A, Itoi T, Endo M, Kitamura K, Mukaide M, Itokawa F, et al. Pathological features and surgical outcome of pancreaticobiliary maljunction without dilatation of the extrahepatic bile duct. Oncol Rep. 2004; 11: 269-76.
23. Ohuchida J, Chijiiwa K, Hiyoshi M, Kobayashi K, Konomi H, Tanaka M,. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation. Arch Surg. 2006; 141: 1066-70.
24. Ando H, Ito T, Nagaya M, Watanabe Y, Seo T, Kaneko K,. Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg. 1995; 30: 1658-62.
25. Matsubara T, Sakurai Y, Zhi LZ, Miura H, Ochiai M, Funabiki T,. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 2002; 9: 312-21.
26. Yamagiwa H,. Mucosal dysplasia of gallbladder: isolated and adjacent lesions to carcinoma. Jpn J Cancer Res. 1989; 80: 238-43.
27. Roa I, de Aretxabala X, Araya JC, Roa J,. Preneoplastic lesions in gallbladder cancer. J Surg Oncol. 2006; 93: 615-23.
28. Chijiiwa K, Tanaka M,. Polypoid lesion of the gallbladder: indications of carcinoma and outcome after surgery for malignant polypoid lesion. Int Surg. 1994; 79: 106-9.
29. Kubota K, Bandai Y, Noie T, Ishizaki Y, Teruya M, Makuuchi M,. How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery. 1995; 117: 481-7.
30. Park JK, Yoon YB, Kim YT, Ryu JK, Yoon WJ, Lee SH, et al. Management strategies for gallbladder polyps: is it possible to predict malignant gallbladder polyps? Gut Liver. 2008; 2: 88-94.
31. Kwon W, Jang JY, Lee SE, Hwang DW, Kim SW,. Clinicopathologic features of polypoid lesions of the gallbladder and risk factors of gallbladder cancer. J Korean Med Sci. 2009; 24: 481-7.
32. Cha BH, Hwang JH, Lee SH, Kim JE, Cho JY, Kim H, et al. Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder. World J Gastroenterol. 2011; 17: 2216-22.
33. Myers RP, Shaffer EA, Beck PL,. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol. 2002; 16: 187-94.
34. Mainprize KS, Gould SW, Gilbert JM,. Surgical management of polypoid lesions of the gallbladder. Br J Surg. 2000; 87: 414-17.
35. Akatsu T, Aiura K, Shimazu M, Ueda M, Wakabayashi G, Tanabe M, et al. Can endoscopic ultrasonography differentiate nonneoplastic from neoplastic gallbladder polyps? Dig Dis Sci. 2006; 51: 416-21.
36. Sugiyama M, Atomi Y, Yamato T,. Endoscopic ultrasonography for differential diagnosis of polypoid gall bladder lesions: analysis in surgical and follow up series. Gut. 2000; 46: 250-4.
37. Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M,. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg. 2009; 208: 134-47.
38. Slattery JM, Sahani DV,. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist. 2006; 11: 913-22.
39. Albu S, Tantau M, Sparchez Z, Branda H, Suteu T, Badea R, et al. Diagnosis and treatment of extrahepatic cholangiocarcinoma: results in a series of 124 patients. Rom J Gastroenterol. 2005; 14: 33-36.
40. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM,. Biliary tract cancers. N Engl J Med. 1999; 341: 1368-78.
41. Silecchia G, Raparelli L, Jover Navalon JM, Gomez AS, Azcoita MM, Materia A, et al. Laparoscopic cholecystectomy and incidental carcinoma of the extrahepatic bilary tree. Jsls. 2002; 6: 339-44.
42. Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg. 2009; 144: 441-447; discussion 447.
43. Kim JH, Kim MJ, Chung JJ, Lee WJ, Yoo HS, Lee JT,. Differential diagnosis of periampullary carcinomas at MR imaging. Radiochemistry. 2002; 22: 1335-52.
44. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002; 51 (Suppl 6): Vi1-9.
45. Unno M, Okumoto T, Katayose Y, Rikiyama T, Sato A, Motoi F, et al. Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg. 2007; 14: 434-40.
46. Endo I, Shimada H, Sugita M, Fujii Y, Morioka D, Takeda K, et al. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery. 2007; 142: 666-75.
47. Chen HW, Lai EC, Pan AZ, Chen T, Liao S, Lau WY,. Preoperative assessment and staging of hilar cholangiocarcinoma with 16-multidetector computed tomography cholangiography and angiography. Hepatogastroenterology. 2009; 56: 578-83.
48. Kumaran V, Gulati S, Paul B, Pande K, Sahni P, Chattopadhyay K,. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol. 2002; 12: 1993-99.
49. Kalra N, Suri S, Gupta R, Natarajan SK, Khandelwal N, Wig JD, et al. MDCT in the staging of gallbladder carcinoma. AJR Am J Roentgenol. 2006; 186: 758-62.
50. Engels JT, Balfe DM, Lee JK,. Biliary carcinoma: CT evaluation of extrahepatic spread. Radiology. 1989; 172: 35-40.
51. Ohtani T, Shirai Y, Tsukada K, Hatakeyama K, Muto T,. Carcinoma of the gallbladder: CT evaluation of lymphatic spread. Radiology. 1993; 189: 875-80.
52. Kim SJ, Lee JM, Lee JY, Choi JY, Kim SH, Han JK, et al. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol. 2008; 190: 74-80.
53. Miyazaki M, Ohtsuka M, Miyakawa S, Nagino M, Yamamoto M,., Kokudo N, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3rd English edition. J Hepatobiliary Pancreat Sci. 2015; 22: 181-96.
54. Yamaguchi K, Enjoji M, Kitamura K,. Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc. 1990; 36: 588-92.
55. Selvaggi SM,. Biliary brushing cytology. Cytopathology. 2004; 15: 74-79.
56. Wu LM, Jiang XX, Gu HY, Xu X, Zhang W, Lin LH, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy in the evaluation of bile duct strictures and gallbladder masses: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2011; 23: 113-20.
57. Varadarajulu S, Eloubeidi MA,. Endoscopic ultrasound-guided fine-needle aspiration in the evaluation of gallbladder masses. Endoscopy. 2005; 37: 751-4.
58. Hijioka S, Hara K, Mizuno N, Imaoka H, Ogura T, Haba S, et al. Diagnostic yield of endoscopic retrograde cholangiography and of EUS-guided fine needle aspiration sampling in gallbladder carcinomas. J Hepatobiliary Pancreat Sci. 2012; 19: 650-5.
59. Gleeson FC, Rajan E, Levy MJ, Clain JE, Topazian MD, Harewood GC, et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2008; 67: 438-43.
60. Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol. 2004; 99: 45-51.
61. Lee JH, Salem R, Aslanian H, Chacho M, Topazian M,. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol. 2004; 99: 1069-73.
62. DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S,. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc. 2006; 64: 325-33.
63. Ohshima Y, Yasuda I, Kawakami H, Kuwatani M, Mukai T, Iwashita T, et al. EUS-FNA for suspected malignant biliary strictures after negative endoscopic transpapillary brush cytology and forceps biopsy. J Gastroenterol. 2011; 46: 921-8.
64. Jacobson BC, Waxman I, Parmar K, Kauffman JM, Clarke GA, Van Dam J,. Endoscopic ultrasound-guided gallbladder bile aspiration in idiopathic pancreatitis carries a significant risk of bile peritonitis. Pancreatology. 2002; 2: 26-9.
65. Cozzi G, Alasio L, Civelli E, Colnago MF, Salvetti M, Pilotti S, et al. Percutaneous intraductal sampling for cyto-histologic diagnosis of biliary duct strictures. Tumori. 1999; 85: 153-6.
66. Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y,. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010; 97: 1860-6.
67. Sakata J, Shirai Y, Wakai T, Nomura T, Sakata E, Hatakeyama K,. Catheter tract implantation metastases associated with percutaneous biliary drainage for extrahepatic cholangiocarcinoma. World J Gastroenterol. 2005; 11: 7024-7.
68. Nakayama A, Imamura H, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S,. Proximal bile duct stricture disguised as malignant neoplasm. Surgery. 1999; 125: 514-21.
69. Liu F, Li Y, Wei Y, Li B,. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci. 2011; 56: 663-72.
70. Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013; 100: 274-83.
71. Hemming AW, Mekeel K, Khanna A, Baquerizo A, Kim RD,. Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg. 2011; 212: 604-13; discussion 613-606.
72. Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci. 2010; 17: 476-89.
73. Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, et al. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012; 19: 1602-8.
74. Igami T, Nishio H, Ebata T, Yokoyama Y, Sugawara G, Nimura Y, et al. Surgical treatment of hilar cholangiocarcinoma in the new era the Nagoya University experience. J Hepatobiliary Pancreat Sci. 2010; 17: 449-54.
75. Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A,. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013; 257: 191-204.
76. Kawakami H, Kuwatani M, Onodera M, Haba S, Eto K, Ehira N, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol. 2011; 46: 242-8.
77. Hirano S, Tanaka E, Tsuchikawa T, Matsumoto J, Kawakami H, Nakamura T, et al. Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014; 21: 533-40.
78. Arakura N, Takayama M, Ozaki Y, Maruyama M, Chou Y, Kodama R, et al. Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2009; 16: 473-7.
79. Kawashima H, Itoh A, Ohno E, Itoh Y, Ebata T, Nagino M, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg. 2013; 257: 121-7.
80. Noie T, Sugawara Y, Imamura H, Takayama T, Makuuchi M,. Selective versus total drainage for biliary obstruction in the hepatic hilus: an experimental study. Surgery. 2001; 130: 74-81.
81. Ishizawa T, Hasegawa K, Sano K, Imamura H, Kokudo N, Makuuchi M,. Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy. Am J Surg. 2007; 193: 149-54.
82. Kloek JJ, van der Gaag NA, Aziz Y, Rauws EA, van Delden OM, Lameris JS, et al. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg. 2010; 14: 119-25.
83. Maguchi H, Takahashi K, Katanuma A, Osanai M, Nakahara K, Matuzaki S, et al. Preoperative biliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2007; 14: 441-6.
84. Kanai M, Nimura Y, Kamiya J, Kondo S, Nagino M, Miyachi M, et al. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery. 1996; 119: 498-504.
85. Watanabe K, Yokoyama Y, Kokuryo T, Kawai K, Kitagawa T, Seki T, et al. Segmental cholangitis impairs hepatic regeneration capacity after partial hepatectomy in rats. HPB (Oxford). 2010; 12: 664-73.
86. Jagannath P, Dhir V, Shrikhande S, Shah RC, Mullerpatan P, Mohandas KM,. Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy. Br J Surg. 2005; 92: 356-61.
87. Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T,. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006; 244: 240-7.
88. Sakata J, Shirai Y, Tsuchiya Y, Wakai T, Nomura T, Hatakeyama K,. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg. 2009; 394: 1065-72.
89. Povoski SP, Karpeh MS, Jr., Conlon KC, Blumgart LH, Brennan MF,. Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg. 1999; 3: 496-505.
90. Cortes A, Sauvanet A, Bert F, Janny S, Sockeel P, Kianmanesh R, et al. Effect of bile contamination on immediate outcomes after pancreaticoduodenectomy for tumor. J Am Coll Surg. 2006; 202: 93-99.
91. Sugawara G, Ebata T, Yokoyama Y, Igami T, Takahashi Y, Takara D, et al. The effect of preoperative biliary drainage on infectious complications after hepatobiliary resection with cholangiojejunostomy. Surgery. 2013; 153: 200-10.
92. Hochwald SN, Burke EC, Jarnagin WR, Fong Y, Blumgart LH,. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 1999; 134: 261-6.
93. Takara D, Sugawara G, Ebata T, Yokoyama Y, Igami T, Nagino M,. Preoperative biliary MRSA infection in patients undergoing hepatobiliary resection with cholangiojejunostomy: incidence, antibiotic treatment, and surgical outcome. World J Surg. 2011; 35: 850-7.
94. Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T,. Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg. 1996; 83: 1345-9.
95. Welsh FK, Ramsden CW, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, et al. Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg. 1998; 227: 205-12.
96. Kamiya S, Nagino M, Kanazawa H, Komatsu S, Mayumi T, Takagi K, et al. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg. 2004; 239: 510-7.
97. Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML,. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut. 1994; 35: 467-70.
98. Luman W, Cull A, Palmer KR,. Quality of life in patients stented for malignant biliary obstructions. Eur J Gastroenterol Hepatol. 1997; 9: 481-4.
99. Abraham NS, Barkun JS, Barkun AN,. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002; 56: 835-41.
100. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB,. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994; 344: 1655-60.
101. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K,. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992; 340: 1488-92.
102. Lammer J, Hausegger KA, Fluckiger F, Winkelbauer FW, Wildling R, Klein GE, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996; 201: 167-72.
103. Krokidis M, Fanelli F, Orgera G, Bezzi M, Passariello R, Hatzidakis A,. Percutaneous treatment of malignant jaundice due to extrahepatic cholangiocarcinoma: covered Viabil stent versus uncovered Wallstents. Cardiovasc Intervent Radiol. 2010; 33: 97-106.
104. Saleem A, Leggett CL, Murad MH, Baron TH,. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc 2011; 74: 321-7. e321-323.
105. Wagner HJ, Knyrim K, Vakil N, Klose KJ,. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy. 1993; 25: 213-8.
106. Mukai T, Yasuda I, Nakashima M, Doi S, Iwashita T, Iwata K, et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepatobiliary Pancreat Sci. 2013; 20: 214-22.
107. Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg. 2007; 193: 702-6.
108. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001; 234: 507-17; discussion 517-509.
109. Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008; 98: 485-9.
110. Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K,. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg. 2000; 87: 418-22.
111. Patel T,. Cholangiocarcinoma - controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011; 8: 189-200.
112. Wittekind C, Yamasaki S,. Extahepatic bile ducts-perihilar. In:, Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours, 7th ed. Hoboken, NJ, USA: Wiley-Blackwell; 2009. p. 122-5.
113. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999; 230: 808-18; discussion 819.
114. Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, et al. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg. 2010; 251: 281-6.
115. Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010; 252: 115-23.
116. Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, et al. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery. 2007; 141: 581-8.
117. Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y,. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg. 2007; 14: 351-7.
118. Regimbeau JM, Fuks D, Bachellier P, Le Treut YP, Pruvot FR, Navarro F, et al. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol. 2011; 37: 505-12.
119. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990; 107: 521-7.
120. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology. 1995; 21: 434-9.
121. Komori K, Nagino M, Nimura Y,. Hepatocyte morphology and kinetics after portal vein embolization. Br J Surg. 2006; 93: 745-51.
122. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003; 237: 208-17.
123. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN,. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg. 2002; 137: 675-80; discussion 680-671.
124. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003; 238: 73-83.
125. Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T,. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg. 2007; 14: 455-62.
126. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y,. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006; 243: 364-72.
127. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S,. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003; 238: 84-92.
128. Grandadam S, Compagnon P, Arnaud A, Olivie D, Malledant Y, Meunier B, et al. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Ann Surg Oncol. 2010; 17: 3155-61.
129. Ito F, Cho CS, Rikkers LF, Weber SM,. Hilar cholangiocarcinoma: current management. Ann Surg. 2009; 250: 210-8.
130. Sirichindakul B, Nonthasoot B, Taesombat W, Supaphol J, Nivatvongs S, Janchai A, et al. Role of portal vein embolization in hepatobiliary malignancy. Hepatogastroenterology. 2007; 54: 2297-300.
131. Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nagino M,. Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg. 2012; 29: 23-9.
132. Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009; 11: 445-51.
133. Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009; 250: 540-8.
134. Hong YK, Choi SB, Lee KH, Park SW, Park YN, Choi JS, et al. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. Eur J Surg Oncol. 2011; 37: 237-44.
135. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997; 26: 1176-81.
136. Suda K, Ohtsuka M, Ambiru S, Kimura F, Shimizu H, Yoshidome H, et al. Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies. Am J Surg. 2009; 197: 752-8.
137. Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M,. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010; 97: 1260-8.
138. Mizumoto R, Kawarada Y, Suzuki H,. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet. 1986; 162: 153-8.
139. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S,. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990; 14: 535-43; discussion 544.
140. Sugiura Y, Nakamura S, Iida S, Hosoda Y, Ikeuchi S, Mori S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery. 1994; 115: 445-51.
141. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M,. Hilar cholangiocarcinoma-surgical anatomy and curative resection. Journal of Hepato-Biliary-Pancreatic Surgery. 1995; 2: 239-48.
142. Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, et al. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci. 2010; 17: 470-5.
143. Unno M, Katayose Y, Rikiyama T, Yoshida H, Yamamoto K, Morikawa T, et al. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010; 17: 463-9.
144. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010; 17: 455-62.
145. Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 2000; 7: 155-62.
146. Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S,. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2000; 7: 148-54.
147. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M,. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999; 230: 663-71.
148. Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Shimizu Y, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery. 1998; 123: 131-6.
149. Kow AW, Wook CD, Song SC, Kim WS, Kim MJ, Park HJ, et al. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg. 2012; 36: 1112-21.
150. Wahab MA, Sultan AM, Salah T, Fathy O, Elebidy G, Elshobary M, et al. Caudate lobe resection with major hepatectomy for central cholangiocarcinoma: is it of value? Hepatogastroenterology. 2012; 59: 321-4.
151. Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J,. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg. 2006; 93: 1488-94.
152. Dinant S, Gerhards MF, Busch OR, Obertop H, Gouma DJ, Van Gulik TM,. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005; 7: 263-7.
153. Lee SG, Lee YJ, Park KM, Hwang S, Min PC,. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg. 2000; 7: 135-41.
154. Gazzaniga GM, Filauro M, Bagarolo C, Mori L,. Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg. 2000; 7: 122-7.
155. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y,. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003; 238: 720-7.
156. Kurosaki I, Hatakeyama K, Minagawa M, Sato D,. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor. J Gastrointest Surg. 2008; 12: 907-18.
157. Yamanaka N, Yasui C, Yamanaka J, Ando T, Kuroda N, Maeda S, et al. Left hemihepatectomy with microsurgical reconstruction of the right-sided hepatic vasculature. A strategy for preserving hepatic function in patients with proximal bile duct cancer. Langenbecks Arch Surg. 2001; 386: 364-8.
158. Sakamoto Y, Sano T, Shimada K, Kosuge T, Kimata Y, Sakuraba M, et al. Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbecks Arch Surg. 2006; 391: 203-8.
159. Reddy YP, Sheridan WG,. Port-site metastasis following laparoscopic cholecystectomy: a review of the literature and a case report. Eur J Surg Oncol. 2000; 26: 95-8.
160. Wullstein C, Woeste G, Barkhausen S, Gross E, Hopt UT,. Do complications related to laparoscopic cholecystectomy influence the prognosis of gallbladder cancer? Surg Endosc. 2002; 16: 828-32.
161. Jin K, Lan H, Zhu T, He K, Teng L,. Gallbladder carcinoma incidentally encountered during laparoscopic cholecystectomy: how to deal with it. Clin Transl Oncol. 2011; 13: 25-33.
162. Wibbenmeyer LA, Wade TP, Chen RC, Meyer RC, Turgeon RP, Andrus CH,. Laparoscopic cholecystectomy can disseminate in situ carcinoma of the gallbladder. J Am Coll Surg. 1995; 181: 504-10.
163. Z'Graggen K, Birrer S, Maurer CA, Wehrli H, Klaiber C, Baer HU,. Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinoma. Surgery. 1998; 124: 831-8.
164. Paolucci V, Schaeff B, Schneider M, Gutt C,. Tumor seeding following laparoscopy: international survey. World J Surg. 1999; 23: 989-95; discussion 996-987.
165. Lundberg O, Kristoffersson A,. Port site metastases from gallbladder cancer after laparoscopic cholecystectomy. Results of a Swedish survey and review of published reports. Eur J Surg. 1999; 165: 215-22.
166. Lundberg O, Kristoffersson A,. Open versus laparoscopic cholecystectomy for gallbladder carcinoma. J Hepatobiliary Pancreat Surg. 2001; 8: 525-9.
167. Wakai T, Shirai Y, Hatakeyama K,. Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy. World J Surg. 2002; 26: 867-71.
168. Ouchi K, Mikuni J, Kakugawa Y,. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg. 2002; 9: 256-60.
169. Weiland ST, Mahvi DM, Niederhuber JE, Heisey DM, Chicks DS, Rikkers LF,. Should suspected early gallbladder cancer be treated laparoscopically? J Gastrointest Surg. 2002; 6: 50-6; discussion 56-57.
170. Sano T, Ajiki T, Hirata K, Okazaki T, Fujino Y, Suzuki Y, et al. A recurrent case of an early gallbladder carcinoma after laparoscopic cholecystectomy. Hepatogastroenterology. 2004; 51: 672-4.
171. Yoshida T, Matsumoto T, Sasaki A, Morii Y, Ishio T, Bandoh T, et al. Laparoscopic cholecystectomy in the treatment of patients with gall bladder cancer. J Am Coll Surg. 2000; 191: 158-63.
172. Whalen GF, Bird I, Tanski W, Russell JC, Clive J,. Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg. 2001; 192: 189-95.
173. Sarli L, Contini S, Sansebastiano G, Gobbi S, Costi R, Roncoroni L,. Does laparoscopic cholecystectomy worsen the prognosis of unsuspected gallbladder cancer? Arch Surg. 2000; 135: 1340-4.
174. de Aretxabala XA, Roa IS, Mora JP, Orellana JJ, Riedeman JP, Burgos LA, et al. Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer. World J Surg. 2004; 28: 544-7.
175. Kokudo N, Makuuchi M, Natori T, Sakamoto Y, Yamamoto J, Seki M, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003; 138: 741-50; discussion 750.
176. Varshney S, Butturini G, Gupta R,. Incidental carcinoma of the gallbladder. Eur J Surg Oncol. 2002; 28: 4-10.
177. Zhang WJ, Xu GF, Zou XP, Wang WB, Yu JC, Wu GZ, et al. Incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy. World J Surg. 2009; 33: 2651-6.
178. Yamamoto H, Hayakawa N, Kitagawa Y, Katohno Y, Sasaya T, Takara D, et al. Unsuspected gallbladder carcinoma after laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg. 2005; 12: 391-8.
179. Choi SB, Han HJ, Kim CY, Kim WB, Song TJ, Suh SO, et al. Incidental gallbladder cancer diagnosed following laparoscopic cholecystectomy. World J Surg. 2009; 33: 2657-63.
180. Suzuki S, Yokoi Y, Kurachi K, Inaba K, Ota S, Azuma M, et al. Appraisal of surgical treatment for pT2 gallbladder carcinomas. World J Surg. 2004; 28: 160-5.
181. Wakai T, Shirai Y, Yokoyama N, Ajioka Y, Watanabe H, Hatakeyama K,. Depth of subserosal invasion predicts long-term survival after resection in patients with T2 gallbladder carcinoma. Ann Surg Oncol. 2003; 10: 447-54.
182. Shimizu Y, Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004; 136: 1012-7; discussion 1018.
183. Choi SB, Han HJ, Kim CY, Kim WB, Song TJ, Suh SO, et al. Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection. J Gastrointest Surg. 2010; 14: 668-78.
184. Chijiiwa K, Nakano K, Ueda J, Noshiro H, Nagai E, Yamaguchi K, et al. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg. 2001; 192: 600-7.
185. Schauer RJ, Meyer G, Baretton G, Schildberg FW, Rau HG,. Prognostic factors and long-term results after surgery for gallbladder carcinoma: a retrospective study of 127 patients. Langenbecks Arch Surg. 2001; 386: 110-7.
186. Shirai Y, Yoshida K, Tsukada K, Muto T,. Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg. 1992; 215: 326-31.
187. Goetze TO, Paolucci V,. Prognosis of incidental gallbladder carcinoma is not influenced by the primary access technique: analysis of 837 incidental gallbladder carcinomas in the German Registry. Surg Endosc. 2013; 27: 2821-8.
188. Shukla PJ, Barreto G, Kakade A, Shrikhande SV,. Revision surgery for incidental gallbladder cancer: factors influencing operability and further evidence for T1b tumours. HPB (Oxford). 2008; 10: 43-7.
189. Hueman MT, Vollmer CM, Jr., Pawlik TM,. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009; 16: 2101-15.
190. Tarazi RY, Hermann RE, Vogt DP, Hoerr SO, Esselstyn CB, Jr., Cooperman AM, et al. Results of surgical treatment of periampullary tumors: a thirty-five-year experience. Surgery. 1986; 100: 716-23.
191. Knox RA, Kingston RD,. Carcinoma of the ampulla of Vater. Br J Surg. 1986; 73: 72-3.
192. Goldberg M, Zamir O, Hadary A, Nissan S,. Wide local excision as an alternative treatment for periampullary carcinoma. Am J Gastroenterol. 1987; 82: 1169-71.
193. Sharp KW, Brandes JL,. Local resection of tumors of the ampulla of Vater. Am Surg. 1990; 56: 214-7.
194. Klein P, Reingruber B, Kastl S, Dworak O, Hohenberger W,. Is local excision of pT1-ampullary carcinomas justified? Eur J Surg Oncol. 1996; 22: 366-71.
195. Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T,. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999; 134: 526-32.
196. Branum GD, Pappas TN, Meyers WC,. The management of tumors of the ampulla of Vater by local resection. Ann Surg. 1996; 224: 621-7.
197. de Castro SM, van Heek NT, Kuhlmann KF, Busch OR, Offerhaus GJ, van Gulik TM, et al. Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival. Surgery 2004; 136: 994-1002.
198. Roggin KK, Yeh JJ, Ferrone CR, Riedel E, Gerdes H, Klimstra DS, et al. Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms. Ann Surg Oncol. 2005; 12: 971-80.
199. Ito K, Fujita N, Noda Y, Kobayashi G, Obana T, Horaguchi J, et al. Impact of technical modification of endoscopic papillectomy for ampullary neoplasm on the occurrence of complications. Dig Endosc. 2012; 24: 30-5.
200. Yoon YS, Kim SW, Park SJ, Lee HS, Jang JY, Choi MG, et al. Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg. 2005; 242: 92-100.
201. Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y,. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg. 2002; 89: 1260-7.
202. Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg. 1998; 227: 405-11.
203. Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg. 2009; 249: 296-302.
204. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K,. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005; 103: 1210-6.
205. Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, et al. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007; 31: 1788-96.
206. Ojima H, Kanai Y, Iwasaki M, Hiraoka N, Shimada K, Sano T, et al. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci. 2009; 100: 62-70.
207. Nakanishi Y, Kondo S, Zen Y, Yonemori A, Kubota K, Kawakami H, et al. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci. 2010; 17: 166-73.
208. Higuchi R, Ota T, Araida T, Kobayashi M, Furukawa T, Yamamoto M,. Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery. 2010; 148: 7-14.
209. Shingu Y, Ebata T, Nishio H, Igami T, Shimoyama Y, Nagino M,. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery. 2010; 147: 49-56.
210. Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A,. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg. 2010; 97: 1363-8.
211. Ribero D, Amisano M, Lo Tesoriere R, Rosso S, Ferrero A, Capussotti L,. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg. 2011; 254: 776-81; discussion 781-773.
212. Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today. 2009; 39: 770-9.
213. Tsukada K, Hatakeyama K, Kurosaki I, Uchida K, Shirai Y, Muto T, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996; 120: 816-21.
214. Sakamoto Y, Kosuge T, Shimada K, Sano T, Hibi T, Yamamoto J, et al. Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol. 2006; 94: 298-306.
215. Okusaka T, Ishii H, Funakoshi A, Yamao K, Ohkawa S, Saito S, et al. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol. 2006; 57: 647-53.
216. Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C,. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer. 2004; 91: 1769-74.
217. Furuse J, Okusaka T, Boku N, Ohkawa S, Sawaki A, Masumoto T, et al. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study. Cancer Chemother Pharmacol. 2008; 62: 849-55.
218. Kanai M, Yoshimura K, Tsumura T, Asada M, Suzuki C, Niimi M, et al. A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer. Cancer Chemother Pharmacol. 2011; 67: 1429-34.
219. Sasaki T, Isayama H, Nakai Y, Ito Y, Kogure H, Togawa O, et al. Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol. 2010; 65: 1101-7.
220. Morizane C, Okusaka T, Mizusawa J, Takashima A, Ueno M, Ikeda M, et al. Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805). Cancer Sci. 2013; 104: 1211-6.
221. Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, et al. A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer. Cancer Chemother Pharmacol. 2013; 71: 973-9.
222. Valle JW, Wasan H, Johnson P, Jones E, Dixon L, Swindell R, et al. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study-The UK ABC-01 Study. Br J Cancer. 2009; 101: 621-7.
223. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010; 362: 1273-81.
224. Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010; 103: 469-74.
225. Shinchi H, Takao S, Nishida H, Aikou T,. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol. 2000; 75: 89-94.
226. Shinohara ET, Mitra N, Guo M, Metz JM,. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol, Biol, Phys. 2009; 74: 1191-8.
227. Valek V, Kysela P, Kala Z, Kiss I, Tomasek J, Petera J,. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. Eur J Radiol. 2007; 62: 175-9.
228. Alden ME, Mohiuddin M,. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol, Biol, Phys. 1994; 28: 945-51.
229. Takamura A, Saito H, Kamada T, Hiramatsu K, Takeuchi S, Hasegawa M, et al. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol, Biol, Phys. 2003; 57: 1357-65.
230. Shinohara ET, Guo M, Mitra N, Metz JM,. Brachytherapy in the treatment of cholangiocarcinoma. Int J Radiat Oncol, Biol, Phys. 2010; 78: 722-8.
231. Shin HS, Seong J, Kim WC, Lee HS, Moon SR, Lee IJ, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol, Biol, Phys. 2003; 57: 105-12.
232. Zen Y, Sasaki M, Fujii T, Chen TC, Chen MF, Yeh TS, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct - an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol. 2006; 44: 350-8.
233. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC,. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Am J Surg Pathol. 2010; 34: 27-34.
234. Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y,. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol. 2008; 39: 1153-61.
235. Itatsu K, Zen Y, Ohira S, Ishikawa A, Sato Y, Harada K, et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007; 27: 1174-84.
236. Rougemont AL, Genevay M, McKee TA, Gremaud M, Mentha G, Rubbia-Brandt L,. Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. Virchows Arch. 2010; 456: 711-7.
237. Stancu M, Caruntu ID, Giusca S, Dobrescu G,. Hyperplasia, metaplasia, dysplasia and neoplasia lesions in chronic cholecystitis-a morphologic study. Rom J Morphol Embryol. 2007; 48: 335-42.
238. Duarte I, Llanos O, Domke H, Harz C, Valdivieso V,. Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer. 1993; 72: 1878-84.
239. Laitio M., Histogenesis of epithelial neoplasms of human gallbladder I. Dysplasia Pathol Res Pract. 1983; 178: 51-6.
240. Roa JC, Roa I, Correa P, Vo Q, Araya JC, Villaseca M, et al. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. J Gastroenterol. 2005; 40: 79-86.
241. Garcia P, Manterola C, Araya JC, Villaseca M, Guzman P, Sanhueza A, et al. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions. Mol Carcinog. 2009; 48: 79-89.
242. Kaiser A, Jurowich C, Schonekas H, Gebhardt C, Wunsch PH,. The adenoma-carcinoma sequence applies to epithelial tumours of the papilla of Vater. Z Gastroenterol. 2002; 40: 913-20.
243. Baczako K, Buchler M, Beger HG, Kirkpatrick CJ, Haferkamp O,. Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol. 1985; 16: 305-10.
244. Takashima M, Ueki T, Nagai E, Yao T, Yamaguchi K, Tanaka M, et al. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol. 2000; 13: 1300-7.
245. Howe JR, Klimstra DS, Cordon-Cardo C, Paty PB, Park PY, Brennan MF,. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res. 1997; 3: 129-33.
246. Krones E, Graziadei I, Trauner M, Fickert P,. Evolving concepts in primary sclerosing cholangitis. Liver Int. 2012; 32: 352-69.
247. Takikawa H, Manabe T,. Primary sclerosing cholangitis in Japan - analysis of 192 cases. J Gastroenterol. 1997; 32: 134-7.
248. Tanaka A, Takamori Y, Toda G, Ohnishi S, Takikawa H,. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Liver Int. 2008; 28: 983-9.
249. Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012; 19: 536-42.
250. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004; 28: 1193-203.
251. Albores-Saavedra J, Langeles-Angeles A,. Diseases of gallbladder. In:, Burt A, Portman B, Ferrell L, editors. MacSewwn's pathology of the liver. 6th ed. Edinburg, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto: Churchill Libingstone; 2011. p. 563-97.
252. Sawada S, Harada K, Isse K, Sato Y, Sasaki M, Kaizaki Y, et al. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction. Pathol Int. 2007; 57: 652-63.
253. Nishimura A, Shirai Y, Hatakeyama K,. Segmental adenomyomatosis of the gallbladder predisposes to cholecystolithiasis. J Hepatobiliary Pancreat Surg. 2004; 11: 342-7.